Personalized drug testing to guide liver cancer treatment after surgery
Treatments studied
Part of Cancer clinical trials.
This trial uses a test on your tumor (an 'organoid') to pick which medicines might work best for you after surgery. The goal is to lower the chance of your liver cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have primary liver cancer (hepatocellular carcinoma) that was removed by surgery, and your tumor shows certain high-risk features.
- Your liver function is good or only mildly impaired (Child-Pugh class A or B).
- You are physically active and able to care for yourself (ECOG score 0 or 1).
- Your blood counts and kidney function meet the study's safety limits.
- You agree to use effective contraception during the study and for a period after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with early-stage liver cancer who are scheduled for surgery. It uses a simple blood test to look for tiny bits of tumor DNA after treatment, which may help predict if the cancer will come back.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This trial tests whether using a lab-grown 'mini-tumor' (organoid) made from your cancer cells can help pick a more effective treatment for liver cancer that can't be removed with surgery. The goal is to find a drug that works specifically for your cancer.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
This study uses a 3D-printed model of your liver tumor to help doctors choose treatment that may prevent the cancer from coming back after surgery. The model predicts how your tumor might respond, so you get the most effective therapy.
This trial tests a tailored treatment plan after surgery for liver cancer that shows a specific blood vessel pattern (VETC). The goal is to find the best follow-up therapy to lower the chance of cancer coming back.
Hear when a new Hepatocellular Carcinoma Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.